Jim Simons Rocket Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 461,374 shares of RCKT stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

461,374

Previous 338,474 36.31%

Holding current value

$1.85 Million

Previous $2.26 Million 49.93%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.33 - $8.01 $286,357 - $984,429	122,900 Added 36.31%	461,374 $1.13 Million
Q1 2025 May 14, 2025	BUY	$6.67 - $12.72 $800,099 - $1.53 Million	119,955 Added 54.89%	338,474 $2.26 Million
Q4 2024 Feb 13, 2025	BUY	$11.35 - $18.82 $2.48 Million - $4.11 Million	218,519 New	218,519 $2.75 Million
Q2 2024 Aug 09, 2024	BUY	$20.66 - $26.72 $2.06 Million - $2.66 Million	99,574 New	99,574 $2.14 Million
Q4 2023 Feb 13, 2024	SELL	$16.78 - $31.94 $2.19 Million - $4.18 Million	-130,800 Reduced 67.61%	62,674 $1.88 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $2.48 Million - $3.96 Million	164,600 Added 570.06%	193,474 $3.96 Million
Q2 2023 Aug 11, 2023	SELL	$16.59 - $23.6 $1.4 Million - $1.99 Million	-84,500 Reduced 74.53%	28,874 $574,000
Q1 2023 May 12, 2023	SELL	$15.79 - $22.6 $717,276 - $1.03 Million	-45,426 Reduced 28.61%	113,374 $1.94 Million
Q4 2022 Feb 13, 2023	SELL	$15.5 - $22.76 $4.98 Million - $7.31 Million	-321,000 Reduced 66.9%	158,800 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $567,783 - $845,019	45,900 Added 10.58%	479,800 $7.66 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $2.21 Million - $4.62 Million	277,400 Added 177.25%	433,900 $5.97 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $61,865 - $111,319	4,701 Added 3.1%	156,500 $2.48 Million
Q4 2021 Feb 11, 2022	BUY	$21.52 - $36.02 $781,305 - $1.31 Million	36,306 Added 31.44%	151,799 $3.31 Million
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $2.62 Million - $4.67 Million	95,393 Added 474.59%	115,493 $3.45 Million
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $1.4 Million - $1.68 Million	-35,490 Reduced 63.84%	20,100 $890,000
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $2.41 Million - $3.66 Million	55,590 New	55,590 $2.47 Million
Q2 2020 Aug 13, 2020	SELL	$13.32 - $22.61 $1.25 Million - $2.12 Million	-93,600 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$9.71 - $25.11 $908,856 - $2.35 Million	93,600 New	93,600 $1.31 Million
Q4 2019 Feb 13, 2020	SELL	$11.07 - $24.23 $308,853 - $676,017	-27,900 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$10.85 - $14.78 $302,715 - $412,362	27,900 New	27,900 $325,000
Q2 2019 Aug 12, 2019	SELL	$15.0 - $19.81 $259,515 - $342,732	-17,301 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$13.45 - $19.01 $249,053 - $352,008	-18,517 Reduced 51.7%	17,301 $303,000
Q4 2018 Feb 13, 2019	BUY	$11.21 - $23.53 $401,519 - $842,797	35,818 New	35,818 $531,000

Others Institutions Holding RCKT

# of Institutions

220

Shares Held

98.5M

Call Options Held

611K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $303M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account